Video testimonials from patients

Stephen, liver cancer, USA

Stephen  was diagnosed with cholangiocarcinoma (liver cancer) stage IV in april 2018. Back then, he was given a life expectancy of 8 to 11 months – the doctors said that he would be gone by the middle of 2019. Stephen came to Immucura in november 2018 to receive the dendritic cell vaccine. See what he has to say about his current state!

 

David, pancreatic cancer, Spain

David was diagnosed with pancreatic cancer in December 2015. The third chemotherapy had to be interrupted due to internal bleedings. At the end of 2018 he got sent home into palliative care. That is when David came to Immucura in december 2018 to do dendritic cell therapy – and he is still with us today!

See other blog posts

Read yourself throug the news at Immucura Med.

Video testimonials from patients

Video testimonials from patients Stephen, liver cancer, USA Stephen  was diagnosed with cholangiocarcinoma (liver cancer) stage IV in april 2018. Back then, he was given a life expectancy of 8 to 11 months - the doctors said that he would be gone by the middle of...

Welcoming Dr Edgar Remmel to Immucura’s medical board

Welcoming Dr Edgar Remmel to Immucura’s medical board Interview with Johannes Schumacher (founder of Immucura Med) and Dr. Remmel Dr. med Edgar Alexander Remmel is a recognized German surgeon an immunotherapist. After 15 years of working with minimal invasive surgery,...

Offering German medicine in sunny Spain!

Offering German medicine in sunny Spain! Production of the Dendritic Cell Vaccine Hi, this is Johannes, I am the founder of Immucura Med. I just returned from Germany where I was visiting the laboratory and where I had a couple of meetings. It amazes me every time to...

Immucura’s new medical director

Introducing Dr Ramón Simon-López Immucura's new medical director Immucura Med is more than happy to introduce Dr. Ramon Simon-Lopez as the new medical director. He is a well-know hemato-oncologist and former member of the WHO Executive Board. He has made more than 100...